3 US Growth Stocks With High Insider Ownership And Earnings Growth Up To 61%
In This Article:
As the U.S. stock market continues to reach new heights, driven by strong performances in sectors like semiconductors and artificial intelligence, investors are increasingly focused on growth opportunities with robust fundamentals. In this environment, companies with high insider ownership and significant earnings growth potential can be particularly attractive, as they often indicate strong alignment between management and shareholder interests.
Top 10 Growth Companies With High Insider Ownership In The United States
| Name | Insider Ownership | Earnings Growth |
| Atlas Energy Solutions (NYSE:AESI) | 29.1% | 41.9% |
| Atour Lifestyle Holdings (NasdaqGS:ATAT) | 26% | 23.4% |
| GigaCloud Technology (NasdaqGM:GCT) | 25.7% | 26% |
| Victory Capital Holdings (NasdaqGS:VCTR) | 10.2% | 33.2% |
| Super Micro Computer (NasdaqGS:SMCI) | 25.7% | 28.0% |
| Hims & Hers Health (NYSE:HIMS) | 13.7% | 37.4% |
| EHang Holdings (NasdaqGM:EH) | 32.8% | 81.4% |
| Credo Technology Group Holding (NasdaqGS:CRDO) | 14.0% | 95% |
| Carlyle Group (NasdaqGS:CG) | 29.5% | 22% |
| BBB Foods (NYSE:TBBB) | 22.9% | 51.2% |
We're going to check out a few of the best picks from our screener tool.
Liquidia
Simply Wall St Growth Rating: ★★★★★☆
Overview: Liquidia Corporation is a biopharmaceutical company that develops, manufactures, and commercializes products addressing unmet patient needs in the United States, with a market cap of $981.32 million.
Operations: Revenue Segments (in millions of $): Liquidia generates revenue primarily from its Pharmaceuticals segment, amounting to $14.84 million.
Insider Ownership: 10.6%
Earnings Growth Forecast: 57.5% p.a.
Liquidia is positioned as a growth company with significant insider ownership, evidenced by substantial insider buying over the past three months. The company's revenue is forecast to grow at 57% annually, outpacing the US market average. Despite recent shareholder dilution and volatile share prices, Liquidia's strategic expansion through an amended licensing agreement with Pharmosa Biopharm enhances its market reach. The expected profitability within three years and favorable clinical trial data for L606 support its growth trajectory.
-
Unlock comprehensive insights into our analysis of Liquidia stock in this growth report.
-
Our valuation report unveils the possibility Liquidia's shares may be trading at a premium.
GigaCloud Technology
Simply Wall St Growth Rating: ★★★★★★
Overview: GigaCloud Technology Inc. offers comprehensive B2B ecommerce solutions for large parcel merchandise both in the United States and internationally, with a market cap of approximately $1.02 billion.